Genetic dissection of the role of p21Cip1/Waf1 in p53-mediated tumour suppression

Oncogene

Volumn 26, Issue 11, 2007, Pages 1645-1649

  Efeyan, A ^a   Collado, M ^a   Velasco Miguel, S ^a   Serrano, M ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Apoptosis; Cancer; Cell cycle; p21; p53; Tumour suppression

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE ARREST; CONTROLLED STUDY; EXPERIMENTAL MODEL; FIBROSARCOMA; GENE; MEDIATOR; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; APOPTOSIS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; MICE; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MUS;

EID: 33947125103     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209972     Document Type: Article

References (32)

1. Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ, Sebti SM. (2000). Loss of p21WAF1/CIP1 accelerates ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene 19: 5338-5347.
2. Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ. (2002). Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties. Cancer Res 62: 2077-2084.
3. Bissonnette N, Hunting DJ. (1998). p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene 16: 3461-3469.
4. Brugarolas J, Bronson RT, Jacks T. (1998). p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J Cell Biol 141: 503-514.
5. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. (1995). Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
6. De la Cueva E, Garcia-Cao I, Herranz M, Lopez P, Garcia-Palencia P, Flores JM et al. (2006). Tumorigenic activity of p21(Waf1/Cip1) in thymic lymphoma. Oncogene 6: 4128-4132.
7. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
8. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
9. Fan S, Chang JK, Smith ML, Duba D, Fornace Jr AJ, O'Connor PM. (1997). Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene 14: 2127-2136.
10. Fotedar R, Bendjennat M, Fotedar A. (2004). Role of p21 (WAF1) in the cellular response to UV. Cell Cycle 3: 134-137.
11. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. (2000). Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 20: 6147-6158.
12. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM et al. (2002). 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J 21: 6225-6235.
13. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
14. Jackson RJ, Adnane J, Coppola D, Cantor A, Sebti SM, Pledger WJ. (2002). Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models. Oncogene 21: 8486-8497.
15. Jackson RJ, Engelman RW, Coppola D, Cantor AB, Wharton W, Pledger WJ. (2003). p21Cip1 nullizygosity increases tumor metastasis in irradiated mice. Cancer Res 63: 3021-3025.
16. Komarova EA, Kondratov RV, Wang K, Christov K, Golovkina TV, Goldblum JR et al. (2004). Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene 23: 3265-3271.
17. Lowe SW, Ruley HE. (1993). Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7: 535-545.
18. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
19. Martin-Caballero J, Flores JM, Garcia-Palencia P, Collado M, Serrano M. (2004). Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice. Oncogene 23: 8231-8237.
20. Martin-Caballero J, Flores JM, Garcia-Palencia P, Serrano M. (2001). Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 61: 6234-6238.
21. Palmero I, Serrano M. (2001). Induction of senescence by oncogenic ras. Methods Enzymol 333: 247-256.
22. Philipp J, Vo K, Gurley KE, Seidel K, Kemp CJ. (1999). Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis. Oncogene 18: 4689-4698.
23. Poole AJ, Heap D, Carroll RE, Tyner AL. (2004). Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon. Oncogene 23: 8128-8134.
24. Samuel T, Weber HO, Funk JO. (2002). Linking DNA damage to cell cycle checkpoints. Cell Cycle 1: 162-168.
25. Strathdee G, Sansom OJ, Sim A, Clarke AR, Brown R. (2001). A role for mismatch repair in control of DNA ploidy following DNA damage. Oncogene 20: 1923-1927.
26. Topley GI, Okuyama R, Gonzales JG, Conti C, Dotto GP. (1999). p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc Natl Acad Sci USA 96: 9089-9094.
27. Vousden KH, Lu X. (2002). Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604.
28. Vousden KH, Prives C. (2005). P53 and prognosis: new insights and further complexity. Cell 120: 7-10.
29. Weinberg WC, Fernandez-Salas E, Morgan DL, Shalizi A, Mirosh E, Stanulis E et al. (1999). Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis. Cancer Res 59: 2050-2054.
30. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
31. Yang W, Velcich A, Lozonschi I, Liang J, Nicholas C, Zhuang M et al. (2005). Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice. Am J Pathol 166: 1239-1246.
32. Yang WC, Mathew J, Velcich A, Edelmann W, Kucherlapati R, Lipkin M et al. (2001). Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res 61: 565-569.